Stage III Splenic Marginal Zone Lymphoma

Explore clinical trials studying Stage III Splenic Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Stage III Splenic Marginal Zone Lymphoma trial results

Active, Not Recruiting

NCT03198026

Conditions: Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Follicular Lymphoma, +26 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States